Transcriptomic landscape based on annotated clinical features reveals PLPP2 involvement in lipid raft-mediated proliferation signature of early-stage lung adenocarcinoma

Table 1 Clinical information of included patients

	Cohort 1 (n%)	Cohort 2 (n%)	t/χ²	P
Patient Number	30	128
Sample Number	60	256
Age	64.13 ± 11.05	60.10 ± 9.58	2.01	0.05*
Gender			0.72	0.40
Female	21 (70.00)	79 (61.72)
Male	9 (30.00)	49 (38.28)
Smoking status			1.70	0.19
Non-smoker	21 (70.00)	73 (57.03)
Smoker	9 (30.00)	55 (42.97)
Lesion maximum diameter (cm)	2.04 ± 0.66	3.33 ± 1.88	-6.26	< 0.01**
Lesion site			10.93	0.03*
Right upper lobe	14(48.28)	31 (24.22)
Right middle lobe	2 (6.90)	15 (11.72)
Right lower lobe	2 (6.90)	27 (21.09)
Left upper lobe	2 (6.90)	26 (20.31)
Left lower lobe	9 (31.03)	29 (22.66)
TNM Stage			45.86	< 0.01**
Stage 0	8 (26.67)	0 (0.00)
Stage I	22 (73.33)	80 (62.50)
Stage II	0 (0.00)	11 (8.59)
Stage III	0 (0.00)	21 (16.41)
Stage IV	0 (0.00)	16 (12.50)

ISSN: 1756-9966